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A META-ETHNOGRAPHY OF ADULT SMOKERS’ EXPLORING THE 
MEANINGS OF TOBACCO DEPENDENCY MEDICATION ADHERENCE 
BEHAVIOURS DURING SMOKING CESSATION.  
 
Word count: 4,805 
 
INTRODUCTION 
This paper reports findings of a meta-ethnography of published qualitative research on 
smokers’ experiences, views and beliefs of tobacco dependence medications in community 
settings. Cigarette smoking remains the most important preventable cause of premature death 
and disability worldwide (Killen et al., 2000). Tobacco dependence medications (TDMs) are 
effective at aiding initial abstinence and decreasing lapse risk but the likelihood of long-term 
success remains relatively low (Hughes, Keely, & Naud, 2004; West, 2016). There are seven 
first-line TDMs: five variants of nicotine replacement therapy (NRT), varenicline (Chantix), 
and bupropion sustained release (Zyban). The use of TDMs should be encouraged based on 
the evidence that they make quitting easier (NICE, 2015). However, instead of using one or 
more of the available TDMs, most quit attempts are unassisted (Solberg, Asche, Boyle, 
McCarty, & Thoele, 2007). 
 
Nursing interventions can increase people’s success in quitting smoking (Rice, Hartmann-
Boyce, & Stead, 2013). People who are active participants in managing their health and care 
have better outcomes than those who are passive recipients of care (Foot et al., 2014). Shared 
decision‑making is key to evidence-based practice and aligns with professional regulatory 
bodies which require clinicians to work in partnership with patients (Coulter & Collins, 2011; 
Greenhalgh, 2014; NICE, 2009). Most smokers try to stop but relapse repeatedly (Kirchner, 
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Shiffman, & Wileyto, 2012). Relapse is the fundamental barrier to the management of 
addictive behaviours and the predominant outcome of behaviour change efforts (Brandon & 
Litvin, 2007). The development of TDMs for SC and use of evidence-based guidelines for 
health professionals has increasingly medicalised tobacco dependence (TD), potentially 
undervaluing unassisted quitting and neglecting the views of smokers (Morphett, Partridge, 
Gartner, Carter, & Hall, 2015).  
 
Poor adherence to treatment is a worldwide problem; adherence to long-term therapy for 
chronic illnesses in developed countries averages 50%, the rates are even lower in developing 
countries (WHO, 2003). People are active decision makers who access various sources of 
information regarding medications; they are not passive receivers of medical advice (Britten, 
1996; Pound et al., 2005).  Smokers’ evaluate TDMs and form judegments that are influenced 
by positive beliefs about unassisted quitting (Morphett et al., 2015). Motivation, willpower 
and commitment have been found to be  important to smokers who quit without TDMs 
(Smith, Chapman, & Dunlop, 2015). Chapman and McKenzie (2010) argue “that unassisted 
quitting, or “cold turkey”, has the greatest impact on reducing smoking prevalence and 
accordingly should receive greater clinical and research attention”. Medicine taking 
behaviour per se is complex (Osterberg & Blaschke, 2005). Non-adherence to medication is a 
significant problem; it is estimated that 50% of people with a chronic condition are non-
adherent to their prescribed medications (Bowry, Shrank, Lee, Stedman, & Choudhry, 2011; 
WHO, 2003). Therefore, improved adherence potentially could help improve population 
health (Haynes, McDonald, Garg, & Montague, 2002). Most interventions for enhancing 
medication adherence are not widely effective (Nieuwlaat et al., 2014).  Poor adherence with 
TDM compromises efficacy (Hollands et al., 2015).  
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The nature of TD provides a unique treatment context with specific adherence issues. 
Research is needed to explore the association between TDM adherence and quitting success 
(Raupach, Brown, Herbec, & West, 2013). It is important to optimise adherence with TDMs, 
to achieve a deeper understanding of smokers’ perceptions and why smokers behave in the 
way they do with available TDMs. There is a paucity of qualitative literature regarding the 
experiences and meaningfulness of TD pharmacotherapy. A systematic overview of this work 
has not been previously conducted and it is difficult to draw generalisable conclusions for 
practice. This paper reports use of meta-ethnography to synthesise findings from qualitative 
research studies focused on adult smokers’ experiences, meanings and beliefs regarding 




This study aimed to identify and synthesise the best available qualitative evidence on adult 
smokers’ experiences, meanings and beliefs regarding TDMs and their importance to 
adherence behaviours.  
Review question 
 
What are the tobacco dependence medication experiences of adult smokers’ and how do these 
influence their adherence behaviours?  
 
Design  
This review is a synthesis of qualitative research using the methods of meta-ethnography as 
proposed by Noblit and Hare (Noblit & Hare, 1988). Meta-ethnography is the most 
commonly used meta-synthesis technique for qualitative synthesis (France, Wells, Lang, & 
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Williams, 2016). A robust meta-ethnography can construct new conceptual understandings of 
complex healthcare issues and contribute to the understanding of patient experiences (Atkins 
et al., 2008; Campbell et al., 2011). Meta-ethnography continues to develop and guidance to 
inform the decision-making process at key stages of the qualitative synthesis has been 
developed.  Authors became aware of the eMERGe project (France et al., 2015) after 
undertaking this study and have retrospectively carefully considered the eMERGe reporting 
guidelines (France et al., 2019)  to assure best practice in conducting and sharing our meta-
ethnography has been followed.   
Search methods 
Published literature from Europe and America, written in English between April 2006–
February 2014 was identified from databases during April 2016: CINAHL, MEDLINE, 
EMBASE, British Nursing Index, ASSIA, Web of Science and PsycINFO. Keyword 
searching was used initially by breaking down the research question into the overall main 
ideas; these main ideas formed simple keywords which were used to search library databases. 
Search syntax included terms smoking, smoking cessation, tobacco dependency, medication 
adherence, meaning, experience, belief, attitude, qualitative and various TDM names. These 
terms were used in several combinations using the Boolean operations “AND”, “OR”. 
Truncation enabled searching for a word that could have multiple endings. The authors also 
checked for spelling variations and synonyms. Further, phrase searching helped to narrow the 
search results by allowing authors to define precisely how we wanted the words to appear, for 
example “medication adherence”. Hand searches of reference lists of retrieved articles and 
journals was undertaken; this aimed to ensure complete coverage of articles which may not 
have been indexed by databases. Titles and abstracts of all studies found from the literature 
searches were considered for eligibility. Full text of studies believed potentially eligible were 
obtained and reviewed by authors. Our search aim was not to produce an exhaustive search or 
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comprehensive sample (Noblit & Hare, 1988); rather,  the systematic search was utilised to 
determine a final set of studies via an iterative inclusion and exclusion process that identified 
conceptually rich data in order to contribute to the synthesising of interpretations across 
studies (Malpass et al., 2009). 
 
Search outcome 
The search yielded 724 potentially relevant papers; of these, 704 were excluded because they 
were duplicates, irrelevant, or not qualitative in design. 13 articles were excluded owing to a 
lack of relevance to the review and/or ineligible study design e.g. they did not provide an 
explicit account of a theoretical framework or a clear description of methodology (Figure 1).  
 




A sample of 13 papers were obtained for quality appraisal. Authors firstly considered each 
study’s clarity and methodological quality utilising a standardised appraisal tool from the 
Joanna Briggs Institute (JBI, 2014) (Supporting Information File S1). Secondly, studies were 
evaluated to determine the extent to which they provided a rich account of participants’ 
experiences of TDMs and how these influenced adherence behaviours. Any disagreements 
that arose between authors were resolved through discussion and consensus. A summary 
description of the 7 included studies is given in Table 1.  
 
Table 1 Table of included studies  
 
Data abstraction and synthesis 
A meta-ethnography of adult smokers’ exploring the meanings of tobacco dependency medications 
adherence behaviours during smoking cessation. 
Page 6 of 24 
 
A synthesis of qualitative studies of adult smokers’ perspectives of TDMs published between 
April 2006-February 2014 was undertaken using meta-ethnography. The data was combined 
by following Noblit and Hare’s (1988) rigorous process of reciprocally translating the 
findings from each included study into those from all the other studies in the synthesis 
(Noblit & Hare, 1988). Findings were systematically reviewed and integrated. Extracted data 
were organised by gathering and then organising concepts that contributed to the 
development of three themes (Table 2; Supporting Information File S2). Following this, the 
synthesis was then expressed as a ‘line of argument’ and presented as our model of smokers’ 
TDMs adherence and non-adherence behaviours  (Figure 2).     
Table 2 Translations and lines of argument 
 
Data synthesis consisted of studies that explored the perceptions, experiences and 
expectations of NRT amongst ethnically diverse adult smokers: four studies also included 
Bupropion; none of the studies investigated Varenicline or E-Cigarettes. Study characteristics 
were extracted from the papers using the standardised JBI data extraction tool for Interpretive 
& Critical Research (Supporting Information File S3). The data extraction process was 
undertaken by CJS and checked by AL. First-order findings (quotations) were used to support 
second-order interpretations (authors’ analyses) to gain new insight into the relationships 
between smoking cessation and TDM adherence.  
Active and repeat reading of the included studies determined the final concepts. In this 
process primary themes were located in the results section and interpreted as reflecting 
participants’ understandings, attitudes, meanings and expectations of TDMs within the 
context of smoking cessation (as reported in the included studies). Secondary themes, located 
in the discussion and conclusion section of each study, were understood as authors’ 
interpretations of participants’ understandings. The included papers were processed in 
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chronological order. The first three papers provided the structure into which the remaining 
four papers were translated. Reciprocal Translation Analysis (RTA) (Noblit & Hare, 1988) 
provided the process approach for integrating the data into a coherent argument. This allowed 
for codes to be compared, contrasted and provisionally grouped into broad areas of similarity. 
This generated a reduced set of translations about how TDMs were perceived and 
experienced within the context of smoking cessation in different cultures. Following 
discussions among reviewers (CJS and AL), seven “translations” were created expressed as 
“lines of argument” (Noblit & Hare, 1988) in order to depict facilitators or barriers of TDM 
adherence. All the review themes and subthemes were supported with quotations from the 
original studies and were agreed by all the authors as accurately representing the findings. 
Following the theme development, a refutational analysis (RA) (Noblit & Hare, 1988) was 
undertaken to examine differences across studies. The RA yielded very few differences and 
all authors agreed the findings were coherent with no alternative explanations. This might be 
due to the context of the studies; all the studies were conducted in developed countries where 
participants could access TDMs and support for SC.  
FINDINGS 
 
Evidence from seven papers reported the views, perceptions, attitudes, expectations beliefs 
and experiences of 370+ encompassed diverse cultural/ethnic backgrounds of former or 
current smokers of both genders and aged ≥18 years. Interpretations were mostly limited to a 
description of TDMs use or non-use within a biomedical model, interpreting TDM underuse 
as a deviant behaviour. The rationality of TDM taking and barriers to TDM use was 
predominantly conceptualised as relating to cultural factors, individual misconceptions or 
inadequate understanding of the medication. 
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Participant quotes extracted from included studies are tabulated within Table 3. Resistance to 
medication emerged from the synthesis as important. Smokers’ discourse about TDMs 
challenged medical evidence rather than depicting a passive acceptance of it. The synthesis 
indicated that decision making about TDMs was associated with dynamic processes of 
dealing with Nicotine Withdrawal Symptoms (NWSs) within the context of psychosocial 
factors that mostly supported smoking behaviour and rejected TDM use. Findings are 
presented in three main themes: (i) psychosocial context of TDM behaviours; (ii) willpower 
predilection  and (iii) resisting medications. 
 
Table 3: Participant quotes extracted from included studies 
 
Psychosocial context of TDM behaviours 
 
Smokers face difficult and emotional challenges when they attempt to quit. Habitually 
smoking was seen to be helpful to alleviating high levels of stressful events and compatible 
with social environments. Participants’ narratives suggest TDMs use is embedded in a 
psychosocial context, which is not influenced by existing guidelines for SC. The meaning of 
smoking and cessation were strongly fashioned via dynamic social interactions, conflicts and 
shared cultural traditions and roles. Narratives conveyed a complex, uncomfortable and 
dynamic lived experience of SC. Smokers described conflicts within themselves and with 
their significant others about their smoking choices and subsequent behaviours.  
‘‘I think that made a big impression on me…‘Hey when I grow up I’m going to 
smoke.’’ ‘‘one of the obstacles against quitting I think is friends and family that 
smoke.’’ (Burgess et al., 2007) 
 
This psychosocial context caused abrupt termination of SC decisions resulting in a relapse to 
smoking.  In contrast to positive ideas about smoking, some participants expressed strong 
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dislike of it, explaining the negative impact that smoking has on them personally and also 
their family relationships. Smokers’ narratives revealed conflicting thoughts about SC. Some 
were influenced by their personal relationships to stop smoking but personally had low 
motivation to do so. Most participants were unaware of available TDMs and behavioural 
support. Smokers’ narratives suggested cognitive dissonance (Festinger, 1957) about 
smoking (e.g. believing smoking is harmful and simultaneously holding importance to their 
social interactions). Such conflicting beliefs were uncomfortable and accordingly destabilised 
adherence to TDMs as smokers tended to alter their beliefs intentionally in order to stop the 
cognitive dissonance.  
“Why would you take something to stop smoking and then get three or four different side 
effects? When you only got one with smoking.”(Fu et al., 2007) 
Smoking was a well-established, common behaviour amongst participants; consequently, the 
ease of availability of cigarettes and normalisation of smoking behaviour was evident. The 
presence of smoking among family members and peer groups contributed to the early 
formation of smoking behaviours and was a strong barrier to cessation. Within the included 
studies most beliefs about TDMs had been formed within social contexts where medications 
were feared. Smokers felt they were behaving correctly when they resisted TDMs as rejection 
of medicines was the social norm. Most participants had little understanding of TDMs and 
worried about taking them; paradoxically, the use of TDMs conflicted with their desire to 
stop smoking. 
“Like in every commercial you can see they have like those gross side effects. You know, I’m 
so surprised they only put them on TV. I wouldn’t want any of that type of and I’m so afraid of 
damaging the liver and all the organs inside from taking medicines …” (Burgess et al., 2007) 
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Perceptions of TDMs’ properties detracted from TDM initiation and adherence. Participants, 
who expressed a desire to stop smoking, feared unpleasant nicotine withdrawal symptoms 
(NWSs) and although aware of TDMs their negative perceptions of them stopped them from 
using them. Decisions to use TDMs are not made solely by isolated persons, but rather they 
reflect choices made by groups of people associated to each other both directly and indirectly. 
Smokers are psychosocially connected; this influences their adherence to TDMs fear. 
Willpower predilection  
Unaided SC was cited as the most popular method of quitting. Participants had low 
motivation to use TDMs. Reasons for avoidance of TDMs included fear of side effects, a 
general aversion to medication, connotations of mental illness, or belief that willpower alone 
controls successful cessation. Many participants feared becoming dependent on medicinal 
treatments. They described smoking as more of a personal weakness and a failure of their 
willpower than an illness. These negative attitudes toward pharmacotherapy were linked to 
feelings of mistrust in conventional health care, with natural interventions considered to be 
more desirable. Participants preferred to “tough it out” or use non-medicinal substances to 
help them stop smoking, for example, chewing gum, chamomile tea, fruit, exercise and 
sweets (candy). They used these strategies to alleviate cravings during quitting; these 
“natural” methods were supported by their family members.  
“… it’s just sort of if you take pills to me it’s sort of somehow a sign of giving up and 
being weak. I’d rather do it myself and find the strength myself.” (Vogt, Hall, & 
Marteau, 2008) 
Family members validated the idea that willpower determined SC success rather than using 
TDMs. The perception that “willpower” is superior to TDMs was reinforced by concerns 
about safety quitting using willpower alone provides a sense of accomplishment and 
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demonstrated strength of character. Participants believed that willpower is vital to quitting 
and not having enough willpower a smoker would not be able to stop smoking: 
 ‘‘Well I think it is mainly the willpower. If somebody wants to give the cigarettes up it 
depends how strong he is…nowadays there are lots of expensive cigarette patches and 
everything on the market. I don’t believe they can help somebody to stop smoking if 
they don’t want to’’ (White, Bush, Kai, Bhopal, & Rankin, 2006).  
Use of TDMs was perceived as a weakness and an uncomfortable reflection of having a lack 
of willpower. A perceived lack of willpower was used to  justify their inability to stop 
smoking. Male narratives associated willpower with bravery and strength of character. 
Taking TDMs conflicted with a strongly held belief amongst participants that willpower is 
the remedy to smoking. Capacity for active willpower was limited and not a constantly 
available resource. Inconsistent adherence to TDMs regimens and SC behaviours was 
influenced by the person’s willpower.  
Resisting medications  
‘Resistance to TDMs’ emerged as an important theme for smokers who sought to reconcile 
their smoking, quitting choices and behaviours within complex contexts of long smoking 
histories, failed quit attempts, chronic deprivation and cultural factors. Beliefs and 
interpretations of TDMs were not fixed but oscillated within different SC circumstances. 
These interpretations arguably align with an existing general tendency for people to resist 
taking medicines (Britten, 1996).  
“I just don’t like to take pills,” (Levinson, Borrayo, Espinoza, Flores, & Perez-Stable, 
2006) 
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This predilection to resist medicines resulted in dynamic behaviour with TDMs; deliberately 
choosing to avoid or reduce TDMs was a theme recurring in the studies. Participants had 
knowledge of TDMs (e.g. over the counter NRT) but perceived the taking of medicines as 
undesirable and many of the participants’ feared dependence and strongly resisted TDMs.  
 ‘‘I’m not very much of a pill person…. I think someone taking pills for quit[ting] 
smoking, I’d think they’re crazy….’’(Burgess et al., 2007). 
Non-adherence to TDMs was common because of fears of taking medicines, risk of 
dependency and smokers’ suspicions about the plausibility of their ability to help them stop 
smoking. Worry about side effects is augmented by (i) inaccurate knowledge about the 
potential risks and (ii) the perception of incidence of likely occurrence of harm.  
Paradoxically smoking was often considered safer than using TDMs. Participants actively 
assessed TDMs especially their safety and addictive potential. NRT and bupropion were 
regarded differently as TDMs. NRTs were partially understood regarding how they stopped 
cravings or replaced the purpose of cigarettes (or not). Some participants understood that the 
nicotine in NRT reduced or stopped cravings for cigarettes.  However, not all participants 
shared this view of NRT and were unconvinced nicotine replacement was plausible. Some 
participants recognised that NRT was safer than continued smoking, but this belief was 
incongruent with stronger negative opinions and scepticism of NRT. 
The idea of taking bupropion met with more apprehension amongst participants than NRT 
use. Bupropion was perceived more as a medicine owing to its oral dose form; this connected 
strongly with attitudes against medication and intensified worries about side effects. 
Bupropion was considered a potent drug; this led to perceptions of it being dangerous, a 
powerful chemical substance and unnatural. For some participants the interpretation of 
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bupropion as being powerful was the attraction for its use. However, participants quickly 
rejected it if they knew it as an anti-depressant.  
“They say it’s an antidepressant . . . and I don’t take antidepressants, so I don’t take 
Zyban® [bupropion].” (Levinson et al., 2006) 
‘‘I am quite sceptical about tablets and stuff so I wouldn’t want to get into that habit. 
I wouldn’t be happy about using Zyban’’ (White et al., 2006) 
This knowledge provoked negative views associated with mental health problems, fear of 
side effects, and general dislike of medicines. Bupropion was generally perceived as having 
dangerous adverse effects and was viewed as interfering with the body’s natural state.  
Perceptions about TDMs appear to also be formed within an economic discourse; e.g. 
comparing the financial costs of TDMs with that of cigarettes. Resistance to TDMs appeared 
to be a complex combination of individual and social group beliefs. The extent to which 
TDMs were resisted depended on how they were perceived within their social network and 
strength of preference for resisting medication. 
In summary, the synthesis findings show that while smokers aspire to quit smoking and 
consider using TDMs, the psychosocial context, predilection for willpower and “natural” 
methods to achieve quit success and a tendency to resist medications undermine their 
medication adherence behaviours.  TDM adherence emerged as multifactorial with different 
‘moderators’ being shaped by different contexts. Beliefs and perceptions surrounding the 
importance of willpower in the SC process emerged as important. High resistance towards 
TDMs was evident, despite participants struggling to stop smoking. This indicates that 
smokers may have specific reasons for poor medication adherence compared to other 
medication conditions. There was a strong preference for “natural” methods to aid cessation.  
A meta-ethnography of adult smokers’ exploring the meanings of tobacco dependency medications 




There are several key factors involved here. Facilitators and barriers are neither constant nor 
binary influences on smokers’ TDM adherence behaviour. Participants were uncertain about 
safety, efficacy and functional benefits of TDMs. Smokers perceptions of TDMs appeared to 
be shaped by their judgement of the ability of TDMs to control cravings to smoke. Most 
participants preferred to avoid the use TDMs. A dislike of medications in general contributed 
to a negative view of TDMs specifically. This dynamic cognition undermines the dominant 
medical discourse regarding SC that strongly asserts the efficacy of behavioural support and 
TDMs for SC (Stead et al., 2012). 
 
“I don’t think that people can follow directions very well, so that is one main reason 
why it doesn’t work.”(Carpenter, Ford, Cartmell, & Alberg, 2011) 
 
‘Resistance’ regarding medication taking emerged as a concept from a previous qualitative 
synthesis. Medication resistance has previously been defined as “the ways in which people 
take medicines and attempt to minimise their intake” (Pound et al., 2005). This work has been 
further developed (Britten, Riley, & Morgan, 2010) and the concept of resistance has been 
updated as referring to the various ways in which people behave with medicines. Although 
most participants resisted TDMs, some positive attributes of TDMs were expressed, mainly 
by those who had experienced the benefits of TDMs in previous quit attempts. Most 
participants preferred willpower alone; this has been found in other studies (Etter & 
Schneider, 2013; Smith, Carter, Chapman, Dunlop, & Freeman, 2015). Willpower preference 
and resistance to TDMs needs to be acknowledged by nurses and used to inform tailor TDM 
adherence advice. Arguably willpower is an underestimated concept, though commonly 
associated with SC by smokers, clinicians and researchers. It is likely that different 
stakeholders within SC have a different understanding of what willpower means. It would be 
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beneficial to explore willpower within health behaviour change and establish its relationship 
to medication adherence.  
 
Developing the model 
 
The line of argument synthesis generated a model of smokers TDMs adherence and non-
adherence behaviours (Figure 2). The model depicts the inter-relationship between the 
identified themes illustrating smokers’ TDM adherence and non-adherence behaviours. It 
depicts oscillation between psychosocially driven beliefs about TDMs that mostly do not 
resonate with the current medical model of TD treatment. TDMs were mostly judged 
ineffective, resisted and rejected because of potential side effects, not as effective as 
willpower and inability to address reasons for smoking other than nicotine addiction. Factors 
identified from the line-of-argument translation operate as facets of smokers’ experiences of 
smoking, SC and medication beliefs within the real world. All which create an insecure 
milieu for TDM adherence behaviour; which oscillates in response. The model does not 
classify smokers into fixed categories or locate them on a specific trajectory of adherence 
behaviour at a given time point. The complexity of the effect of facilitators and barriers is 
significant; they are neither constant and nor binary influences on smokers’ TDM adherence 
behaviour. Unpleasant NWSs fit with the medical model of TD addiction and need for a 
pharmacological approach; this conflicts with a preference for willpower and natural methods 
to quit smoking.  
 
Figure 2 A model of smokers TDMs adherence and non-adherence behaviours 
 
Central to the model is the smoker within their dynamic TDM adherence behaviours. 
Smokers’ narratives revealed the presence of psychological discomfort from conflicting 
attitudes or beliefs about SC and use of TDMs, which resonated with Festinger’s cognitive 
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dissonance theory (Festinger, 1957). TDMs emerged as ambiguous aids to quitting whose 
meanings were still being negotiated. Arguably smokers’ oscillating SC thoughts and TDM 
use is a representation of inconsistent beliefs owing to numerous and conflicting social 
interactions. Smokers’ experience and discourse about TDMs challenged medical evidence 
rather than passive acceptance of it. This synthesis indicates that decision making about 
TDMs was associated with dynamic processes of dealing with NWSs within the context of 
psychosocial factors that mostly supported smoking behaviour and rejected medication use. 
Nurses should ascertain smokers concerns about TDMs. Smokers’ views about the value of 
different TDMs were not independent: attitudes about TDMs were fashioned by positive 
attitudes towards unassisted quitting and willpower.  
 
DISCUSSION   
The aim of this meta-ethnography was to contribute to the debate about adherence to TD 
medication.  Meta-ethnography is a robust method for qualitative synthesis which can 
produce new conceptual understandings of complex health care issues useful to researchers, 
policy makers, managers and practitioners. The reviewers aimed to produce new 
interpretations that surpassed the individual studies on which it is based. However, some 
limitations apply. Because of the intensive work involved in this specific  methodology, there 
is a time-lag between the original database searches and publication. It is recognised that 
searching the qualitative literature can be problematic (Hannes & Macaitis, 2012). Despite 
attempts to undertake a comprehensive search, some studies may have been missed. Studies 
included were descriptive and used thematic analysis; it was unclear if the studies analysed 
the data based on pre-specified theoretical assumptions. None of the papers included a 
definition or theoretical position on medication adherence. Instead, authors presented findings 
as inherently characteristic of smokers’ concerns and the difficulties of SC. This generalised 
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the needs and experiences of smokers and did not address the complexities of adherence to 
TDMs regimens. None of the studies worked from a definition of adherence or within any of 
the available typologies of medication adherence, despite the extensive base of theorisation in 
the literature (Osterberg & Blaschke, 2005; Vermiere, Hearnshaw, Van Royen, & Denekens, 
2001).  Included studies were from either the UK or USA, where SC programmes align with 
similar guidelines and best practices.  However, it is acknowledged that the studies were 
undertaken in differently funded systems of health care limiting the transferability of the 
present findings.  
 
The synthesis revealed diverse concerns and perceptions of TDMs that led to nonadherence 
behaviour. Many of the issues identified were potentially modifiable by behavioural 
interventions. The psychosocial context of TDM behaviours, TDMs resistance and preference 
for willpower emerged from the synthesis as important as this translated into deliberate non-
adherence. Low confidence in TDMs and experienced failure of TDMs to address multi-
faceted and often conflicting reasons for smoking augmented the predilection for willpower. 
These factors legitimised non-adherence behaviours. TDMs were incompatible with 
individuals views and beliefs about taking medications, especially for a long duration. 
Complete TDM adherence and persistence was unachievable within powerful anti-medication 
social contexts and an individual’s desire to be in control of their lives.  Findings of a 
systematic review (Hollands et al., 2015) found limited evidence that interventions focusing 
on improving adherence to TDMs through providing information and facilitating problem
solving can improve adherence. Resistance to TDMs, the role of willpower, the psychosocial 
context of TDM adherence behaviours, the fear of dependency and the preference for 
“natural” methods all need further investigation. A better understanding may help people 
achieve long-term SC. 
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The role of a nurse is well suited to providing SC interventions (Rice et al., 2013). A recent 
meta-synthesis (Malone, Harrison, & DakerWhite, 2018) found tensions between  mental 
health nurses’  perspectives  on  their  role  and  responsibilities  in  providing  SC  support  
and fulfilling service users’ expectations. It is critical for all health professionals to assess the 
person seeking to stop smoking in order to foresee the possible causes of their nonadherence. 
Nurses should facilitate SC by ascertaining TD treatment perceptions, encouraging openness 
about TDM concerns and tailoring support to the individual. In order to improve both the 
quality and the process of TD treatment it is recommended that clinical practice guidelines 
are formulated to optimise medication adherence with TDMs; this would contribute to 
improving the desired outcome – a further reduction in smoking prevalence. Adherence 
support needs to be part of patient-centered care and shared decision-making (NICE, 2009); 
respecting a person’s beliefs about TDMs is fundamental to nursing practice and supporting 
adherence (NMC, 2015). 
 
 
CONCLUSIONS    
This paper is the first metasynthesis to explore TDM adherence. The findings increase 
understanding of the complexity of adult smokers’ experiences, meanings and beliefs 
regarding TDMs and their importance to adherence behaviours. Interventions to improve 
TDM adherence should consider the overarching concepts identified by this meta-
ethnography. TD services and wider healthcare systems need to create policies to support an 
improvement in TDM adherence.  The findings from this meta-ethnography contribute, 
through smokers’ narratives, to articulate the less visible aspects of medication adherence in 
the context of TD.  Nurses should work in partnership with smokers and involve other health 
professionals to help improve TDMs adherence to help achieve improved long-term quit 
outcomes. Research to further understand how a smoker’s predilection for willpower 
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augments the resistance to TDMs is required. Personalised TDM adherence interventions are 
likely to be most effective interventions to help improve long-term SC outcomes. The 
findings of this meta-ethnography are important to future clinical practice guideline 
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